Essex Woodlands Management’s Abiomed Inc ABMD Stock Holding History

Essex Woodlands Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-201,818	Closed	-$58.7M	–	9
2018 Q1	$58.7M	Sell	201,818 -445,000	-69%	-$113M	12.85%	4
2017 Q4	$121M	Sell	646,818 -300,000	-32%	-$56M	21.91%	2
2017 Q3	$160M	Sell	946,818 -503,182	-35%	-$76.1M	28.32%	1
2017 Q2	$208M	Hold	1,450,000	–	–	37.57%	1
2017 Q1	$182M	Hold	1,450,000	–	–	41.42%	1
2016 Q4	$163M	Hold	1,450,000	–	–	37.26%	1
2016 Q3	$186M	Hold	1,450,000	–	–	38.79%	1
2016 Q2	$158M	Hold	1,450,000	–	–	39.93%	1
2016 Q1	$137M	Sell	1,450,000 -700,000	-33%	-$59.1M	35.98%	1
2015 Q4	$194M	Hold	2,150,000	–	–	35.5%	1
2015 Q3	$199M	Hold	2,150,000	–	–	36.46%	1
2015 Q2	$141M	Sell	2,150,000 -1,000,000	-32%	-$66.4M	25.51%	2
2015 Q1	$225M	Hold	3,150,000	–	–	44.73%	1
2014 Q4	$120M	Hold	3,150,000	–	–	37.42%	1
2014 Q3	$78.2M	Hold	3,150,000	–	–	28.48%	2
2014 Q2	$79.2M	Hold	3,150,000	–	–	16.47%	3
2014 Q1	$82M	Hold	3,150,000	–	–	20.88%	3
2013 Q4	$84.2M	Hold	3,150,000	–	–	42.34%	1
2013 Q3	$60M	Hold	3,150,000	–	–	39.64%	1
2013 Q2	$67.9M	Buy	+3,150,000	New	+$63.3M	52.05%	1

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Essex Woodlands Management's ABMD Position: Q2 2018 in Review

Essex Woodlands Management sold out of Abiomed Inc (ABMD) in Q2 2018, closing a stake of 201,818 shares — an estimated $58.7M sold.

Essex Woodlands Management first reported a position in ABMD in Q2 2013 and held it in 20 quarters. The position peaked at $225M in Q1 2015. 527 funds tracked by Wall St. Rank hold ABMD as of Q2 2018.

Essex Woodlands Management reported no remaining Abiomed Inc position as of Q2 2018 after selling out during the quarter.
Essex Woodlands Management sold 201,818 Abiomed Inc shares in Q2 2018, an estimated $58.7M.
Essex Woodlands Management first reported a position in Abiomed Inc in Q2 2013 and held it in 20 quarters.
Essex Woodlands Management's Abiomed Inc position peaked at $225M in Q1 2015.
527 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2018.

Based on Essex Woodlands Management's 13F filing for Q2 2018, filed 14 Aug 2018.